Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
04 January 2023 - 10:09PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of January 2023
Commission File Number: 001-39316
BURNING ROCK BIOTECH LIMITED
(Registrants Name)
No.5 Xingdao
Ring Road North, International Bio Island
Guangzhou, Guangdong
Peoples Republic of China
(Address of principal executive offices)
Indicate by check mark whether
the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
INCORPORATION BY REFERENCE
Exhibit 99.1 of this current report on Form 6-K (the Report) shall be incorporated by reference
into the Companys registration statements on Form F-3, which became effective on September 30, 2022 (File no. 333-264577).
SAFE HARBOR STATEMENT
The press
release included in Exhibit 99.1 of this Report, including the quotes from the Companys management team, contains forward-looking statements. These statements constitute forward-looking statements within the meaning of
Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as will,
expects, anticipates, future, intends, plans, believes, estimates, target, confident and similar statements. Burning Rock may also make
written or oral forward-looking statements in its periodic reports to the SEC, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties.
Statements that are not historical facts, including statements about Burning Rocks beliefs and expectations, are forward-looking statements. Such statements are based upon managements current expectations and current market and operating
conditions, and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond Burning Rocks control. Forward-looking statements involve risks,
uncertainties and other factors that could cause actual results to differ materially from those contained in any such statements. All information provided in this press release is as of the date of this press release, and Burning Rock does not
undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under applicable law.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
Burning Rock Biotech Limited |
|
|
|
|
|
|
|
|
By: |
|
/s/ Leo Li |
|
|
|
|
Name: |
|
Leo Li |
|
|
|
|
Title: |
|
Chief Financial Officer |
|
|
|
|
Date: January 4, 2023 |
|
|
|
|
|
|
4
Burning Rock Biotech (NASDAQ:BNR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Burning Rock Biotech (NASDAQ:BNR)
Historical Stock Chart
From Jul 2023 to Jul 2024